Invion IVIXF Stock
Invion Price Chart
Invion IVIXF Financial and Trading Overview
| Invion stock price | 0.04 USD |
| Previous Close | 0.0041 USD |
| Open | 0.0041 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.0041 - 0.0041 USD |
| 52 Week Range | 0.0041 - 0.0094 USD |
| Volume | 25K USD |
| Avg. Volume | 0 USD |
| Market Cap | 26.33M USD |
| Beta (5Y Monthly) | 1.239463 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.07 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
IVIXF Valuation Measures
| Enterprise Value | 18.29M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 6.6844034 |
| Price/Book (mrq) | 1.3666667 |
| Enterprise Value/Revenue | 4.643 |
| Enterprise Value/EBITDA | -12.678 |
Trading Information
Invion Stock Price History
| Beta (5Y Monthly) | 1.239463 |
| 52-Week Change | -46.75% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.0094 USD |
| 52 Week Low | 0.0041 USD |
| 50-Day Moving Average | 0.0041 USD |
| 200-Day Moving Average | 0.0061124 USD |
IVIXF Share Statistics
| Avg. Volume (3 month) | 0 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 6.42B |
| Float | 3.62B |
| Short Ratio | N/A |
| % Held by Insiders | 47.04% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | -51.42% |
| Operating Margin (ttm) | -51.44% |
| Gross Margin | 26.74% |
| EBITDA Margin | -36.62% |
Management Effectiveness
| Return on Assets (ttm) | -6.29% |
| Return on Equity (ttm) | -10.34% |
Income Statement
| Revenue (ttm) | 3.94M USD |
| Revenue Per Share (ttm) | 0.001 USD |
| Quarterly Revenue Growth (yoy) | 49.79% |
| Gross Profit (ttm) | 969.12K USD |
| EBITDA | -1442561 USD |
| Net Income Avi to Common (ttm) | -2025575 USD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 8.03M USD |
| Total Cash Per Share (mrq) | 0.001 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 13.207 |
| Book Value Per Share (mrq) | 0.003 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -421989 USD |
| Levered Free Cash Flow (ttm) | -4691680 USD |
Profile of Invion
| Country | United States |
| State | VIC |
| City | Melbourne |
| Address | 100 Albert Road |
| ZIP | 3205 |
| Phone | 61 3 9692 7222 |
| Website | https://www.inviongroup.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Invion Limited, a clinical-stage life-sciences company, researches and develops photodynamic therapy for the treatment of various cancers in Australia. The company is developing IVX-PDT, a photosensitizer agent to treat skin cancers, as well as solid cancers, including lung, prostrate, ovarian, and mesothelioma cancers. It has a research and development agreement with Hudson Institute of Medical Research to collaborate on a range of research and development projects for the Photosoft technology for the treatment of a range of cancers; and research agreement with Peter MacCallum Cancer Centre to undertake pre-clinical and in-vitro studies on Invion's IVX-PDT Photodynamic therapy for ano-genital cancers, including penile and anal cancer. The company was incorporated in 2000 and is headquartered in Melbourne, Australia.
Q&A For Invion Stock
What is a current IVIXF stock price?
Invion IVIXF stock price today per share is 0.04 USD.
How to purchase Invion stock?
You can buy IVIXF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Invion?
The stock symbol or ticker of Invion is IVIXF.
Which industry does the Invion company belong to?
The Invion industry is Drug Manufacturers-Specialty & Generic.
How many shares does Invion have in circulation?
The max supply of Invion shares is 133.63M.
What is Invion Price to Earnings Ratio (PE Ratio)?
Invion PE Ratio is now.
What was Invion earnings per share over the trailing 12 months (TTM)?
Invion EPS is -0.07 USD over the trailing 12 months.
Which sector does the Invion company belong to?
The Invion sector is Healthcare.